Someron Tablet (Methylprednisolone)

Adult dosage

The initial dose may vary from 4mg to 48mg per day of methylprednisolone, depending on the symptoms of the specific disease. In general, a low dose is sufficient for less severe conditions, but a high initial dose may be required in certain patients. The initial dose should be maintained or adjusted until a satisfactory response is obtained. If a satisfactory clinical result is not achieved after a reasonable period, treatment should be discontinued and another appropriate treatment initiated. The dose must be determined individually according to the various diseases being treated and the patient's response. After an adequate response is achieved, an appropriate maintenance dose should be determined by reducing the initial dose at suitable intervals until the minimum dose that maintains an adequate clinical response is reached. Continuous monitoring of the dose is required. Situations that may require dose adjustment include improvement or worsening of the disease, individual patient response to the drug, and the effect on the patient of exposure to stressful circumstances that do not directly affect the symptoms of the disease being treated. In the latter case, it may be necessary to increase the dose for a period sufficient to achieve a satisfactory response in the patient's condition. After long-term treatment, gradual dose reduction is recommended when discontinuing the drug. For treatment of acute exacerbations of multiple sclerosis, administration of prednisolone 200mg daily for 1 week followed by prednisolone 80mg every other day for 1 month is effective (4mg of methylprednisolone is equivalent to 5mg of prednisolone). Alternate-day therapy is a regimen in which twice the daily dose is administered on one morning every other day. ADT is a therapeutic technique that should generally be considered for patients requiring long-term corticosteroid drug therapy. The initial suppressive dose should be continued until a satisfactory clinical response is obtained, usually for 4 to 10 days in many allergic and collagen diseases. If difficulties arise, administering 3 or even 4 times the daily dose every other day is preferable to simply doubling the daily dose.

Children's dosage

To minimize adverse effects, including growth suppression in children

This medication should not be administered to specific patients. For instance, patients with allergies to this drug or its components, patients with infections lacking effective antibiotics or systemic fungal infections, patients with herpes simplex, herpes zoster, and chickenpox, as well as those receiving live vaccines or weakened live vaccines should not receive it. Furthermore, caution is advised when prescribing to some patients. Patients with glaucoma, tuberculosis, posterior capsule cataract, electrolyte imbalances, hypertension, thrombosis, recent surgeries, history of acute myocardial infarction, peptic ulcer, mental illness, severe osteoporosis, diabetes, renal failure, hypothyroidism, fatty liver, severe myasthenia gravis, elderly patients, individuals with epilepsy, and patients with ulcerative colitis require special attention when using this drug. Adverse effects may arise from the use of this medication, so symptoms should be monitored closely. Fluid and electrolyte imbalance, muscle and bone issues, gastrointestinal symptoms, skin changes, neuropsychiatric symptoms, endocrine abnormalities, ocular issues, and immune system alterations may occur. Long-term use can result in adrenal insufficiency, and sudden discontinuation can lead to severe withdrawal symptoms, so dosage should be tapered gradually. There is an increased risk of infections, necessitating particular attention to infections, and live vaccinations should be avoided. Women who are pregnant or breastfeeding should only use this medication if absolutely necessary, as it may affect the fetus or newborn, and breastfeeding should be suspended. Pediatric and elderly patients may be more sensitive to side effects, so cautious dosing at the minimum effective dose is advised, with close monitoring of growth and health status. Lastly, exposure to chickenpox or measles while receiving this medication can cause severe complications; therefore, medical history and vaccination statuses should be confirmed, and special care should be taken to prevent infections.

Edema, sodium retention, potassium loss, fluid retention, hypokalemic alkalosis, congestive heart failure, hypertension, myasthenia, aseptic necrosis of the femoral and humeral head, steroid myopathy, loss of muscle mass, pathologic fractures of the pelvis, osteoporosis, spinal compression fractures, arthralgia, tendon rupture, increased ALT, increased AST, increased ALP, nausea, thirst, vomiting, abdominal pain, anorexia, increased appetite, peptic ulcer, abdominal distension, pancreatitis, esophagitis, diarrhea, delayed wound healing, facial erythema, thin and fragile skin, abnormal sweating, petechiae, ecchymosis, suppression of skin reactions, purpura, acne, hirsutism, hair loss, pigmentation, papilledema, increased intracranial pressure, seizures, dizziness, headache, insomnia, euphoria, depression, Cushing's syndrome, menstrual irregularities, growth retardation in children, latent diabetes symptoms, secondary adrenal insufficiency, pituitary unresponsiveness, decreased insulin sensitivity, increased requirements for insulin or oral hypoglycemic agents, suppression of adrenocorticotropic hormone secretion, increased intraocular pressure, glaucoma, subcapsular cataract, secondary eye infections caused by fungi or viruses, retinal disorders, exophthalmos, positive nitrogen balance, immunological disorders, allergic reactions, shock, urticaria, anaphylactic reaction, hypersensitivity reactions

This medication should be stored in a tightly sealed container to prevent air exposure and is best kept at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the drug's efficacy and ensures safe use.

Appearance

White round tablets.

Package unit

30 tablets/bottle, 100 tablets/bottle, for export: 100 tablets (10 tablets/PTP × 10)